PubRank

Daisy Jonkers

Author PubWeight™ 13.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scand J Gastroenterol 2007 2.50
2 GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 2009 1.78
3 Activation of the epithelial-to-mesenchymal transition factor snail mediates acetaldehyde-induced intestinal epithelial barrier disruption. Alcohol Clin Exp Res 2013 1.44
4 The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta 2011 1.43
5 Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. PLoS One 2012 0.98
6 Ethanol disrupts intestinal epithelial tight junction integrity through intracellular calcium-mediated Rho/ROCK activation. Am J Physiol Gastrointest Liver Physiol 2014 0.88
7 New European initiatives in colorectal cancer screening: Budapest Declaration. Official appeal during the Hungarian Presidency of the Council of the European Union under the Auspices of the United European Gastroenterology Federation, the European Association for Gastroenterology and Endoscopy and the Hungarian Society of Gastroenterology. Dig Dis 2012 0.83
8 Enteropathogenic viruses: triggers for exacerbation in IBD? A prospective cohort study using real-time quantitative polymerase chain reaction. Inflamm Bowel Dis 2013 0.83
9 Fatty acid ethyl esters induce intestinal epithelial barrier dysfunction via a reactive oxygen species-dependent mechanism in a three-dimensional cell culture model. PLoS One 2013 0.83
10 The effect of a multispecies probiotic on the composition of the faecal microbiota and bowel habits in chronic obstructive pulmonary disease patients treated with antibiotics. Br J Nutr 2009 0.81
11 Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach. Inflamm Bowel Dis 2015 0.81
12 Pancreatitis-associated protein has no additional value as a marker of disease activity in a real-life cohort of IBD patients. Eur J Gastroenterol Hepatol 2014 0.77
13 Development and Feasibility Study of a Telemedicine Tool for All Patients with IBD: MyIBDcoach. Inflamm Bowel Dis 2017 0.75